World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02447159
Date of registration: 07/05/2015
Prospective Registration: Yes
Primary sponsor: University of California, San Francisco
Public title: Evaluation of Conditional Cash Transfers to Increase Retention in PMTCT Services in Akwa Ibom State, Nigeria
Scientific title: Evaluation of Conditional Cash Transfers to Increase Retention in PMTCT Services in Akwa Ibom State, Nigeria
Date of first enrolment: August 2015
Target sample size: 554
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02447159
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Nigeria
Contacts
Name:     Jenny Liu, PhD, MPP
Address: 
Telephone:
Email:
Affiliation:  University of California, San Francisco
Key inclusion & exclusion criteria

Inclusion Criteria:

- HIV positive

- Pregnant

- Attended an antenatal care visit at one of three participating clinics.

Exclusion Criteria:

- Not HIV positive

- Not pregnant

- Not registered for antenatal care at a participating clinic.



Age minimum: 15 Years
Age maximum: 45 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Pregnancy
Infant, Newborn, Diseases
HIV
HIV Infections
Intervention(s)
Behavioral: Conditional Cash Transfers
Primary Outcome(s)
Number and percentage of pregnant women who deliver their baby at the facility in which they were first enrolled for antenatal care [Time Frame: When the woman delivers her child]
Number and percentage of mothers who obtain early infant diagnosis testing 6-8 weeks after giving birth to their child [Time Frame: 6-8 weeks after the woman delivers her child]
Secondary Outcome(s)
Number and percentage of mothers who pick up Nevirapine for their newborn infant at the facility where they first enrolled in antenatal care after giving birth [Time Frame: 48 hours after the woman delivers her child]
Number and percentage of pregnant women who pick up their antiretroviral treatment drugs at least once between enrolling in antenatal care and giving birth to their baby at the facility where they first enrolled in antenatal care [Time Frame: Between enrollment into antenatal care until the woman delivers her child]
Secondary ID(s)
CCT for PMTCT
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Bill and Melinda Gates Foundation
New Incentives
University of California, Berkeley
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history